ATDC5 Cell Line小鼠畸胎癌細胞株-BioVector NTCC質粒載體菌種細胞蛋白抗體基因保藏中心
- 價 格:¥17952
- 貨 號:ATDC5 Cell Line小鼠畸胎癌細胞株
- 產 地:北京
- BioVector NTCC典型培養物保藏中心
- 聯系人:Dr.Xu, Biovector NTCC Inc.
電話:400-800-2947 工作QQ:1843439339 (微信同號)
郵件:Biovector@163.com
手機:18901268599
地址:北京
- 已注冊
ATDC5 Cell Line小鼠畸胎癌細胞株
BioVector NTCC質粒載體菌種細胞蛋白抗體基因保藏中心www.biovector.net
Cat No.: NTCC592575
Cell Line Name: | ATDC5 |
Keywords: | Mouse 129 teratocarcinoma AT805 derived |
Cell Line Description: | The chondrogenic cell line ATDC5 has been derived from teratocarcinoma AT805. Cells showed a sequential transition of phenotype in vitro. They encompass stages from mesenchymal condensation to calcification. Bone morphogenetic protein-2 (BMP-2) stimulated the sequential progression of early- and late-phase differentiation. Activation of parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor resulted in inhibition of this differentiation capacity. |
Species: | Mouse |
Tissue of Origin: | Unknown |
CellType: | Epithelial-like |
Growth Mode: | Adherent |
Karyotype: | Not specified |
Subculture Routine: | Split sub-confluent cultures (70-80%) i.e. seeding at 1-3 x10,000 cells/cm2 using 0.25% trypsin or trypsin/EDTA;CO2; 37°C subculture every 2-3 days. |
Culture Medium: | DMEM: Ham's F12 (1:1) + 2mM Glutamine + 5% Foetal Bovine Serum (FBS). |
Country: | Japan |
References: | Exp. Cell Res 1998; 241:1, J Bone Miner Res 1997;12:1174 |
- 公告/新聞